Global Interventional Cardiology Devices Market (2018-2023)

The interventional cardiology devices market is a multi-billion-dollar market which includes, but is not limited to, drug-eluting stents, catheters, bare-metal stents, guidewires, and percutaneous transluminal coronary angioplasty. The intervention cardiology devices market provides treatment for a range of cardiovascular diseases including coronary artery disease, peripheral vascular disease, and heart valve disease. The global interventional cardiology devices market is anticipated to expand at a CAGR of 6.04% during the 2018-2023 period, and will reach a value of USD 15.43 Bn by 2023. Rising incidence of cardiovascular diseases, along with the adoption of minimally invasive surgeries is expected to drive the interventional cardiology devices market during the forecast period.
 

Segmentation based on product type
Based on product type, the drug-eluting stents segment contributed the highest revenue in 2018, by replacing the bare-metal stents market, owing to major technological advancements. The segment is anticipated to register a CAGR of 5.71% during the 2018-2023 period, to reach USD 6.71 Bn by 2023. Catheters being the major medium of interventional cardiology procedures, its segment holds a market share of ~27%. The segment is expected to expand at the highest CAGR (7.02%) during the forecast period.

Regional insights
North America accounted for ~38% of the total revenue of the interventional cardiology devices market in 2018, followed by Asia-Pacific (~27%). The Asia-Pacific region is anticipated to expand at the highest CAGR (6.94%) during the forecast period, followed by Latin America, and the Middle East and Africa, expanding at CAGRs of 6.54% and 6.29% respectively. Most of Asia-Pacific’s growth is estimated to come from China, Japan, and India due to the increasing incidence of cardiovascular diseases and rising number of diabetic patients.

Companies profiled
Abbott Laboratories
Boston Scientific Corporation
Medtronic
Terumo Corporation
Edwards Lifesciences Corporation
Becton Dickinson
Johnson & Johnson
B. Braun Melsungen
Teleflex Incorporated
MicroPort Scientific Corporation
 

Chapter 1: Executive Summary

1.1. Market scope and segmentation

1.2. Key questions answered in the study

1.3. Executive summary

Chapter 2: Introduction

2.1. Market definitions

2.2. Market trends

2.3. Market drivers

2.4. Market challenges

2.5. Revenue based on product type - (USD Bn) (2018)

2.6. Value chain analysis of the global interventional cardiology devices market

Chapter 3: Global interventional cardiology devices market overview

3.1. Market overview

3.1.1. Global historical market revenue (USD Bn) (2016-2017)

3.1.2. Global forecast market revenue (USD Bn) (2018-2023)

3.1.3. Geography-wise market revenue (USD Bn) (2018 and 2023)

Chapter 4: Global interventional cardiology devices market - based on product type

4.1. Drug-eluting stents market

4.1.1. Revenue - (2015, 2018 and 2023) (USD Bn)

4.1.2. Trends

4.1.3. Drivers

4.2. Catheters market

4.2.1. Revenue - (2015, 2018 and 2023) (USD Bn)

4.2.2. Trends

4.2.3. Drivers

4.3. Bare-metal stents market

4.3.1. Revenue - (2015, 2018 and 2023) (USD Bn)

4.3.2. Trends

4.3.3. Drivers

4.4. Guidewires market

4.4.1. Revenue - (2015, 2018 and 2023) (USD Bn)

4.4.2. Trends

4.4.3. Drivers

4.5. Other interventional cardiology devices market

4.5.1. Revenue - (2015, 2018 and 2023) (USD Bn)

4.5.2. Trends

4.5.3. Drivers

Chapter 5: Global interventional cardiology devices market - based on regions

5.1. North America

5.1.1. Overview

5.1.2. Revenue - (2015-2023) (USD Bn)

5.1.3. Key highlights

5.2. Europe

5.2.1. Overview

5.2.2. Revenue - (2015-2023) (USD Bn)

5.2.3. Key highlights

5.3. Asia-Pacific

5.3.1. Overview

5.3.2. Revenue - (2015-2023) (USD Bn)

5.3.3. Key highlights

5.4. Latin America

5.4.1. Overview

5.4.2. Revenue - (2015-2023) (USD Bn)

5.4.3. Key highlights

5.5. The Middle East and Africa

5.5.1. Overview

5.5.2. Revenue - (2015-2023) (USD Bn)

5.5.3. Key highlights

Chapter 6: Market share of companies

6.1. Companies’ share in the global interventional cardiology devices market

Chapter 7: Competitive landscape

7.1. Abbott Laboratories

7.1.1. Company snapshot

7.1.2. Key financials

7.1.3. Business description and major products

7.1.4. Global presence

7.1.5. Major initiatives

7.1.6. Growth strategies

Note: Similar information areas will be covered for the competitors

7.2. Boston Scientific Corporation

7.3. Medtronic

7.4. Terumo Corporation

7.5. Edwards Lifesciences Corporation

7.6. Becton Dickinson

7.7. Johnson & Johnson

7.8. B. Braun Melsungen

7.9. Teleflex Incorporated

7.10. MicroPort Scientific Corporation

Chapter 8: Conclusion

8.1. Conclusion

Chapter 9: Appendix

9.1. List of tables

9.2. Assumptions

9.3. Research methodology

9.4. About Research On Global Markets

9.5. Disclaimer
 


Global Hemostasis Diagnostic Analyzers and Reagent Market for over 40 Tests: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

This comprehensive seven-country report contains 650 pages, 150 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the global coagulation

USD 27500 View Report

Global Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: Americas, EMEA, APAC--A 68-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation

This new 68-country report is available by region, country, market segment, section, or individual test. The report is designed to help current suppliers and potential market entrants identify and

USD 45000 View Report

Global Interventional Radiology Products Market Research Report 2019-2023

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Interventional Radiology Products Report by Material, Application, and

USD 2850 View Report

Asia Pacific Interventional Cardiology and Peripheral Vascular Device Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The Asia Pacific Interventional Cardiology and Peripheral Vascular Device market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach

USD 3000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available